Full Text View
Tabular View
No Study Results Posted
Related Studies
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery (STB-01)
This study has been completed.
Study NCT01455233   Information provided by Ophthalmology Consultants, Ltd.

First Received on October 17, 2011.   Last Updated on October 18, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Corneal Health
Cataract Surgery
Additional conditions recognized in this trial
Cataract
More general conditions related to this trial
Eye Diseases
Lens Diseases
Interventions listed in this trial
besivance
vigamox
Additional drug interventions recognized in this trial
Anti-Bacterial Agents
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Infective Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Ophthalmology Consultants, Ltd.
Ophthalmology Associates, St Louis
Bausch & Lomb Incorporated


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services